Global stockmarkets rattled by US inflation surge
Global stockmarkets had their worst week since February after a spike in US inflation worried investors.

“There’s no inflation…nothing to see here…oh…,” says James Knightley of ING. The US Federal Reserve has spent the last few months insisting that talk of impending inflation is overblown. That argument looks harder to sustain after US inflation surged to 4.2% on an annual basis in April, its highest reading since September 2008. Core prices (which exclude volatile food and energy costs) jumped 0.9% in a single month, their biggest monthly rise since 1981. Inflationary pressure will only intensify from here due to a “vibrant, strengthening” recovery in an economy that has “supply constraints”.
The inflation spike has rocked markets. Global stocks had their worst week since February, with the FTSE All-World index finishing last week down 1.5%. The selling continued into this week, with major US and European indices continuing to fall back on Monday. Gold, a traditional inflation hedge, hit a three-month high. Still, a bout of share-price weakness was “overdue” after such a lengthy rally, says Rupert Thompson of Kingswood. For now, the damage looks contained: the S&P 500 hit a new record high just a fortnight ago. A reopening economy had been expected to boost inflation, but not by this much. For markets, “the trillion-dollar question” is whether this is merely transitory, as the Fed insists, or “a sign of things to come”.
The Fed “prides itself” on following the data, says Will Denyer of Gavekal Research. So what about the data that shows US consumer inflation expectations for the year ahead have risen to 4.6%, or the fact that market expectations, as measured by the ten-year breakeven rate – the gap between yields on conventional bonds and inflation-protected bonds – are at “near decade highs”? Even professional forecasters, who are usually sceptical about inflationary talk, now see inflation averaging above the 2% target over the coming decade. The Fed’s ultra-loose monetary policy, which includes near-zero interest rates and $120bn of monthly asset purchases, is increasingly difficult to justify.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Stockmarkets are on thin ice
America is a society where people “are used to getting what they want when they want it”, says The Economist. Yet supplies of everything from chicken breasts to microchips to lumber are running short (see page 5). Used-car prices soared an astounding 10% month-on-month in April. With fiscal and monetary support turbocharging the economy, investors should expect more “inflation scares”.
Central bankers are playing down the inflation threat, but they are hardly neutral observers, says Anthony Rowley in the South China Morning Post. Hiking interest rates would have disastrous consequences for the governments and corporations that have loaded up on debt since the pandemic began: to raise their borrowing costs now would “invite a global debt crisis of fearsome proportions”. Economists and investors had believed for decades that high inflation was a “thing of the past” no matter how low interest rates remained. That “dam of investor confidence” has “been breached”. A “severe market correction” is coming, it is just a question of when.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Could investing in sugar protect you during a downturn?
Sugar has some defensive qualities during economic downturns, but is now the right time to invest in sugar?
By Dan McEvoy
-
Trump’s tariffs: how should the UK respond?
Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism. So, what is Trump thinking?
By Stuart Watkins
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves